Tisotumab vedotin Completed Phase 2 Trials for Non-Small Cell Lung Carcinoma (NSCLC) / Oesophagus Cancer / Endometrial Cancer / Ovarian Cancer / Squamous Cell Carcinoma of the Head and Neck (SCCHN) / Prostate Cancer / Cervix Cancer / Bladder Cancer, Cancer Treatment